Stephanie L Gaw Selected Research

COVID-19

1/2022	Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses.
1/2022	Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.
1/2022	Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity.
12/2021	Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response.
10/2021	Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk.
9/2021	COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads.
5/2021	Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort study.
1/2021	COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
1/2021	Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.
1/2021	Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephanie L Gaw Research Topics

Disease

11	COVID-19 01/2022 - 01/2020
8	Infections 12/2022 - 09/2017
4	Malaria 08/2020 - 10/2017
2	Inflammation (Inflammations) 01/2022 - 12/2021
2	Disease Progression 01/2022 - 12/2021
2	Microcephaly 10/2020 - 10/2018
2	Birth Weight (Birth Weights) 08/2020 - 01/2019
2	Zika Virus Infection 10/2018 - 09/2017
1	Hemorrhage 12/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Vesicular Stomatitis 01/2022
1	Bacterial Infections (Bacterial Infection) 08/2020
1	Aneuploidy (Aneuploid) 12/2017
1	Dengue (Dengue Fever) 09/2017

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2022 - 09/2017
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
6	VaccinesIBA 01/2022 - 01/2020
5	Immunoglobulin G (IgG)IBA 01/2022 - 09/2017
4	mRNA VaccinesIBA 01/2022 - 01/2021
4	Immunoglobulins (Immunoglobulin)IBA 05/2021 - 01/2020
3	COVID-19 VaccinesIBA 01/2022 - 12/2021
3	2019-nCoV Vaccine mRNA-1273IBA 10/2021 - 01/2021
3	Immunoglobulin M (IgM)IBA 05/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2021
2	Neutralizing AntibodiesIBA 01/2022 - 01/2022
2	CytokinesIBA 01/2022 - 08/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 12/2021
2	BNT162 VaccineIBA 09/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2017
1	Viral AntigensIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	IgG Receptors (Fc gamma RI)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	polyoxyethylene allylmethyl diether-maleic anhydride copolymerIBA 10/2020
1	InterferonsIBA 08/2020
1	Interferon Type IIBA 08/2020
1	Interleukin-10 (Interleukin 10)IBA 08/2020
1	hemozoinIBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2018
1	Cell-Free Nucleic AcidsIBA 12/2017

Therapy/Procedure

2	Chemoprevention 08/2020 - 09/2019
2	Therapeutics 06/2020 - 10/2017
1	Blood Transfusion (Blood Transfusions) 12/2022